@techcrunch.com 1 year ago
Visby Medical tests positive for a Series E extension at $1B+ valuation
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@slashgear.com 4 years ago
UDS drug tests show false-positives for these common meds
@techcrunch.com 5 years ago
Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests
@venturebeat.com 5 years ago
Baidu Research’s breast cancer detection algorithm outperforms human pathologists
@techcrunch.com 7 years ago
Theranos starts to agree to things
@techcrunch.com 7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
@venturebeat.com 7 years ago
Microsoft’s LinkedIn open-sources Bluepill for testing iOS apps
@theverge.com 8 years ago
Government report slams Theranos for quality control, unqualified personnel
Google debuts its new health-tracking wearable built for medical studies